AstraZeneca Deserves $76M In Drug Patent Suit, Judge Says
AstraZeneca AB has successfully demonstrated that it is entitled to more than $76 million for Canada-based Apotex Corp. and Torpharm Inc.'s infringement of patents that protected the company's indigestion drug Prilosec,...To view the full article, register now.
Already a subscriber? Click here to view full article